期刊文献+

床边即时脑利钠肽检测对呼吸困难的诊断价值 被引量:30

Diagnoses value of bedside measurement of plasma brain natriuretic in patients with dyspnea
原文传递
导出
摘要 目的 探讨床边即时检测脑利钠肽(BNP)对呼吸困难患者的鉴别诊断价值。方法荧光免疫法测定103例呼吸困难患者血浆BNP,心脏超声和漂浮导管法分别测定心脏左室射血分数和肺毛细血管楔压。结果 (1)心力衰竭(心衰)患者血浆BNP水平明显高于非心衰组患者[(716±86)ng/L与(46±7)ng/L,P<0.01];(2)如以100 ng/L为正常参考值,BNP诊断心衰的敏感性为96.8%,特异性为97.6%,排除心衰的阴性预测价值为97.1%;(3)心衰患者BNP水平与肺毛细血管楔压呈正相关(r=0.43,P<0.01),与左室射血分数呈负相关(r=-0.56,P<0.01)。结论 床边即时检测BNP诊断心衰敏感而且特异,可作为急诊呼吸困难鉴别诊断的一个观察指标。 Objective To investigate differential diagnoses value of ultra-rapid bedside measurement of brain natriuretic peptide (BNP) in patients with dyspnea. Methods Plasma BNP concentration was measured with immunofluorescence assay in 103 patients with dyspnea. Left ventricular ejection fraction (LVEF) and pulmonary capillary wedge pressure (PCWP) were determined by echocardiography and Swan-Ganz catheter in these patients on the same time, respectively. Results (1) Plasma BNP levels in the patients with heart failure were higher than those in the non-heart failure patients [(716±86) ng/L vs. (46±7) ng/L,P <0. 01 ]. (2)The sensitivity, specificity and negative predictive values of plasma BNP levels ≥100 ng/L for predicting heart failure were 96. 8% , 97. 6% and 97. 1 % , respectively. (3) Plasma BNP levels were positively related to PCWP, and negatively related to LVEF (r = -0.56, both P < 0. 01). Conclusion Bedside BNP assay seems sensitive and specific for diagnosing heart failure, and useful in evaluating dyspnea in emergency care.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2004年第12期1123-1125,共3页 Chinese Journal of Cardiology
基金 浙江省卫生科学研究基金资助项目(2003A023)
关键词 BNP 呼吸困难 心衰 床边 患者 诊断 脑利钠肽 负相关 水平 敏感 Heart failure, congestive Dyspnea Natriuretic peptide, brain
  • 相关文献

参考文献10

  • 1Collins SP, Ronan-Bentle S, Storrow AB. Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea. Ann Emerg Med, 2003, 41: 532-545.
  • 2Shapiro BP, Chen HH, Burnett JC Jr, et al. Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure. Mayo Clin Proc, 2003, 78:481-486.
  • 3Tjeerdsma G, de Boer RA, Boomsma F, et al. Rapid bedside measurement of brain natriuretic peptide in patients with chronic heart failure. Int J Cardiol,2002, 86:143-149.
  • 4Latini R, Masson S, de Angelis N, et al. Role of brain natriuretic peptide in the diagnosis and management of heart failure: current concepts.J Card Fail, 2002 , 8:288-299.
  • 5Logeart D. Ultra-rapid measurement of brain natriuretic peptide. Arch Mal Coeur Vaiss, 2002, 95:185-188.
  • 6Peacock WF. The B-type natriuretic peptide assay: a rapid test for heart failure. Cleve Clin J Med, 2002, 69:243-251.
  • 7Valli N, Georges A, Corcuff JB, et al. Assessment of brain natriuretic peptide in patients with suspected heart failure: comparison with radionuclide ventriculography data.Clin Chim Acta, 2001,306:19-26.
  • 8Nicholls MG, Lainchbury JG, Richards AM, et al. Brain natriuretic peptide-guided therapy for heart failure. Ann Med, 2001, 33:422-427.
  • 9Sodian R, Loebe M, Schmitt C, et al. Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. J Am Coll Cardiol, 2001, 38:1942-1949.
  • 10Richards AM, Nicholls MG, Espiner EA, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.Circulation, 2003, 107: 2786-2792.

同被引文献239

引证文献30

二级引证文献196

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部